These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 17258791)

  • 21. Twist confers chemoresistance to anthracyclines in bladder cancer through upregulating P-glycoprotein.
    Chen Y; Li L; Zeng J; Wu K; Zhou J; Guo P; Zhang D; Xue Y; Liang L; Wang X; Chang LS; He D
    Chemotherapy; 2012; 58(4):264-72. PubMed ID: 22986993
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Repression of E-cadherin by SNAIL, ZEB1, and TWIST in invasive ductal carcinomas of the breast: a cooperative effort?
    Montserrat N; Gallardo A; Escuin D; Catasus L; Prat J; Gutiérrez-Avignó FJ; Peiró G; Barnadas A; Lerma E
    Hum Pathol; 2011 Jan; 42(1):103-10. PubMed ID: 20970163
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hypoxia-induced, perinecrotic expression of endothelial Per-ARNT-Sim domain protein-1/hypoxia-inducible factor-2alpha correlates with tumor progression, vascularization, and focal macrophage infiltration in bladder cancer.
    Onita T; Ji PG; Xuan JW; Sakai H; Kanetake H; Maxwell PH; Fong GH; Gabril MY; Moussa M; Chin JL
    Clin Cancer Res; 2002 Feb; 8(2):471-80. PubMed ID: 11839666
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Is overexpression of TWIST, a transcriptional factor, a prognostic biomarker of head and neck carcinoma? Evidence from fifteen studies.
    Zhuo X; Luo H; Chang A; Li D; Zhao H; Zhou Q
    Sci Rep; 2015 Dec; 5():18073. PubMed ID: 26656856
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential expression of the epithelial-mesenchymal transition regulators snail, SIP1, and twist in gastric cancer.
    Rosivatz E; Becker I; Specht K; Fricke E; Luber B; Busch R; Höfler H; Becker KF
    Am J Pathol; 2002 Nov; 161(5):1881-91. PubMed ID: 12414534
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Up-regulation of TWIST in prostate cancer and its implication as a therapeutic target.
    Kwok WK; Ling MT; Lee TW; Lau TC; Zhou C; Zhang X; Chua CW; Chan KW; Chan FL; Glackin C; Wong YC; Wang X
    Cancer Res; 2005 Jun; 65(12):5153-62. PubMed ID: 15958559
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Up-regulation of Twist induces angiogenesis and correlates with metastasis in hepatocellular carcinoma.
    Niu RF; Zhang L; Xi GM; Wei XY; Yang Y; Shi YR; Hao XS
    J Exp Clin Cancer Res; 2007 Sep; 26(3):385-94. PubMed ID: 17987801
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of transcription factor Twist1 in bladder urothelial carcinoma and its clinical significance.
    Tang X; Xing J; Li W; Wu Z; Zhang K; Zheng J
    J BUON; 2013; 18(1):211-9. PubMed ID: 23613408
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Overexpression of matrix metalloproteinase 11 in human gastric carcinoma and its clinicopathologic significance.
    Zhao ZS; Chu YQ; Ye ZY; Wang YY; Tao HQ
    Hum Pathol; 2010 May; 41(5):686-96. PubMed ID: 20060156
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression and significance of twist, E-cadherin, and N-cadherin in gastrointestinal stromal tumors.
    Ding J; Zhang Z; Pan Y; Liao G; Zeng L; Chen S
    Dig Dis Sci; 2012 Sep; 57(9):2318-24. PubMed ID: 22576709
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Twist expression predicts poor clinical outcome of patients with clear cell carcinoma of the ovary.
    Kajiyama H; Hosono S; Terauchi M; Shibata K; Ino K; Yamamoto E; Nomura S; Nawa A; Kikkawa F
    Oncology; 2006; 71(5-6):394-401. PubMed ID: 17690559
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Foxo3a suppression of urothelial cancer invasiveness through Twist1, Y-box-binding protein 1, and E-cadherin regulation.
    Shiota M; Song Y; Yokomizo A; Kiyoshima K; Tada Y; Uchino H; Uchiumi T; Inokuchi J; Oda Y; Kuroiwa K; Tatsugami K; Naito S
    Clin Cancer Res; 2010 Dec; 16(23):5654-63. PubMed ID: 21138866
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Expression of Twist gene in human hepatocellular carcinoma and its clinicopathological significance].
    Li CH; Chen XP; Xu ZQ; Li GP; Guan J
    Zhonghua Wai Ke Za Zhi; 2006 Oct; 44(19):1353-6. PubMed ID: 17217825
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of the transcription factors snail, slug, and twist and their clinical significance in human breast cancer.
    Martin TA; Goyal A; Watkins G; Jiang WG
    Ann Surg Oncol; 2005 Jun; 12(6):488-96. PubMed ID: 15864483
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression profiles of proto-oncogene TWIST1 and tumor metastasis suppressor gene LASS2 in bladder cancer.
    Yegin Z; Aydin O; Koc H; Buyukalpelli R
    Cell Mol Biol (Noisy-le-grand); 2018 Aug; 64(11):66-73. PubMed ID: 30213291
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel role of Id-1 in regulation of epithelial-to-mesenchymal transition in bladder cancer.
    Hu H; Wang YL; Wang GW; Wong YC; Wang XF; Wang Y; Xu KX
    Urol Oncol; 2013 Oct; 31(7):1242-53. PubMed ID: 22226665
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Down-regulating ribonuclease inhibitor enhances metastasis of bladder cancer cells through regulating epithelial-mesenchymal transition and ILK signaling pathway.
    Xiong D; Liou Y; Shu J; Li D; Zhang L; Chen J
    Exp Mol Pathol; 2014 Jun; 96(3):411-21. PubMed ID: 24768914
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of E-cadherin expression by lnc-RNA H19 to facilitate bladder cancer metastasis.
    Zhu Z; Xu L; Wan Y; Zhou J; Fu D; Chao H; Bao K; Zeng T
    Cancer Biomark; 2018; 22(2):275-281. PubMed ID: 29614625
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Altered expression of cell adhesion molecules leads to differential uptake of hypericin in urothelial cancer.
    Olivo M; Lucky SS; Kent Mancer JF; Lau WK
    Urol Oncol; 2012 Sep; 30(5):624-34. PubMed ID: 20933443
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relationship between E-cadherin and fibroblast growth factor receptor 2b expression in bladder carcinomas.
    De Medina SG; Popov Z; Chopin DK; Southgate J; Tucker GC; Delouvée A; Thiery JP; Radvanyi F
    Oncogene; 1999 Oct; 18(41):5722-6. PubMed ID: 10523852
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.